ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated

November 4, 1988

DCBD Board Okays New Program Projects For Diagnosis Research

June 7, 1985

NCI To Fund 3,232, Research Project Grants In Fiscal 1993

January 15, 1993

House Panel Targets AWP For Medicare Drug Pricing.

October 5, 2001

Funding Opportunities: CDC Seeks Initiatives For Tobacco Control; NCI RFA Available

May 8, 1998

“Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says

September 25, 1998